Showing results (281-290 of 484) with videos related to

Sort By:
Pageof 49
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 9, 2021
Focal segmental glomerulosclerosis histologic variants and renal outcomes based on nephrotic syndrome, immunosuppression and proteinuria remissionTakehiko Kawaguchi, Toshiyuki Imasawa, Moritoshi Kadomura, et al.
Clinical and Experimental Nephrology|January 9, 2004
Tranexamic acid-induced visual impairment in a hemodialysis patientHiroshi Kitamura, Isao Matsui, Noriko Itoh, et al.
Anticancer Research|March 31, 2021
Site-specific Response to Nivolumab in Renal Cell CarcinomaTakahito Negishi, Nobuki Furubayashi, Tohru Nakagawa, et al.
BMC Urology|July 27, 2020
The neutrophil-lymphocyte ratio has a role in predicting the effectiveness of nivolumab in Japanese patients with metastatic renal cell carcinoma: a multi-institutional retrospective studyNaotaka Nishiyama, Megumi Hirobe, Takuya Kikushima, et al.
Surgery Today|February 1, 2003
A small, incidentally detected pancreatic somatostatinoma: report of a caseHitoshi Tomono, Hiroshi Kitamura, Masanori Iwase, et al.
Japanese Journal of Clinical Oncology|April 4, 2019
Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup 3-year follow-up analysis from the Phase III CheckMate 025 studyYoshihiko Tomita, Satoshi Fukasawa, Nobuo Shinohara, et al.
Japanese Journal of Clinical Oncology|December 1, 2025
A randomized controlled phase III trial on continued or paused PD-1 pathway blockade for patients with advanced renal cell carcinoma (JCOG1905, STOP study): a study protocolTakashi Matsumoto, Tokiyoshi Tanegashima, Ario Takeuchi, et al.
Cancer Immunology, Immunotherapy : CII|April 21, 2022
Clinical and molecular correlates of response to immune checkpoint blockade in urothelial carcinoma with liver metastasisTakashi Yoshida, Chisato Ohe, Katsuhiro Ito, et al.
Japanese Journal of Clinical Oncology|March 24, 2022
Narrative review of local prostate and metastasis-directed radiotherapy in the treatment of metastatic prostate cancerNaoki Terada, Rihito Aizawa, Keiji Nihei, et al.
Japanese Journal of Clinical Oncology|September 12, 2022
Dissociated response among multiple metastatic lesions in the patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitorsTakahito Negishi, Tohru Nakagawa, Naotaka Nishiyama, et al.
Pageof 49